Literature DB >> 23216799

Safety of human blood products in rare bleeding disorders in southeast of Iran.

M Naderi, P Eshghi, E Saneei Moghaddam, Sh Alizadeh, A Dorgalaleh, M R Younesi, Z K Khateb.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23216799     DOI： 10.1111/hae.12068

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  5 in total

1.  Public Health Problems related to factor V deficiency in southeast of Iran.

Authors:  Majid Naderi; Shadi Tabibian; Akbar Dorgalaleh; Zahra Kashani Kahtib; Shaban Alizadeh
Journal:  Med J Islam Repub Iran       Date:  2014-05-07

2.  Long Term Follow up Study on a Large Group of Patients with Congenital Factor XIII Deficiency Treated Prophylactically with Fibrogammin P®.

Authors:  Majid Naderi; Mehran Karimi; Maryam Sadat Hosseini; Es Hagh Moradi; Morteza Shamsizadeh; Akbar Dorgalaleh
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

3.  Mining of mortality-related findings in rare bleeding disorders: a retrospective study from two centers.

Authors:  Hassan Rafieemehr; Akbar Dorgalaleh; Hassan Mansouritorghabeh
Journal:  Blood Res       Date:  2020-11-24

Review 4.  Current understanding in diagnosis and management of factor XIII deficiency.

Authors:  M Naderi; A Dorgalaleh; Sh Tabibian; Sh Alizadeh; P Eshghi; Gh Solaimani
Journal:  Iran J Ped Hematol Oncol       Date:  2013-10-22

Review 5.  Review of the rational use and adverse reactions to human serum albumin in the People's Republic of China.

Authors:  Ting Zhou; Saihua Lu; Xiufeng Liu; Ye Zhang; Feng Xu
Journal:  Patient Prefer Adherence       Date:  2013-11-28       Impact factor: 2.711
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.